|
Age
| |
Mean= 54 (sd = 13)
|
|
Gender
|
Male
|
142 (56.8%)
|
|
Living alone
|
No
|
194 (77.6%)
|
|
Employed
|
Yes
|
130 (52.0%)
|
|
Education
|
until age 11/12 years
|
33 (13.2%)
|
| |
until age 12/13–14/15 years
|
118 (47.2%)
|
| |
until age 15/16–18/19 years
|
26 (10.4%)
|
| |
advanced (college)
|
73 (29.2%)
|
|
Nationality
|
Swiss
|
209 (83.6%)
|
|
Immunosuppression
|
Cyclosporine & mycophenolate mofetil
|
71 (28.4%)
|
| |
Cyclosporine
|
38 (15.2%)
|
| |
Cyclosporine & azathioprine
|
37 (14.8%)
|
| |
Azathioprine & prednisone
|
18 (7.2%)
|
| |
Azathioprine & tacrolimus
|
14 (5.6%)
|
| |
Other combinations
|
72 (28.8%)
|
|
Monitored immunosuppressives
|
Mycophenolate mofetil
|
103 (41.2%)
|
| |
Cyclosporine
|
89 (35.6%)
|
| |
Azathioprine/prednisone
|
19 (7.6%)
|
| |
Tacrolimus
|
37 (14.8%)
|
| |
Sirolimus
|
2 (0.8%)
|
|
Self-reported EM influence on typical adherence
|
No influence
|
188 (76.1%)
|
| |
Positive influence
|
53 (21.5%)
|
| |
Negative influence
|
6 (2.4%)
|
